Regulatory Affairs

SHRI SAMBHAV REGULATORY SERVICES

Shri Sambhav Regulatory Service is a professional regulatory affairs consultancy dedicated to providing comprehensive pharmaceutical regulatory solutions to pharmaceutical manufacturers, exporters, importers, and healthcare companies worldwide. We specialize in drug registration support, dossier preparation, regulatory compliance, and market authorization services for various international markets.

Core Expertise:

  • CTD Dossier Preparation

  • ACTD Dossier Preparation

  • Country-Specific Dossiers

  • New Product Registration

  • Regulatory Compliance

  • Variation & Renewal Management

  • Contract Manufacturing Support

  • Global Pharmaceutical Registration Services

Proven Compliance

Zero-Delay Market Authorization

100%

Technical audit pass rate

5+

Global regions supported

24 hr

Initial gap analysis turnaround

Our Vision

To become a trusted global regulatory partner by delivering excellence in pharmaceutical regulatory affairs, dossier preparation, and compliance management.

Core Formats

Technical Dossier Formats

CTD Formats
Regional Compliance
Emerging Markets

CTD Modules 1-5

ACTD Alignment

Country-Specific Customization

Complete compilation of Common Technical Documents in strict alignment with international health authority guidelines. We manage Modules 1 through 5 with absolute technical accuracy to pre-empt reviewer queries.

Comprehensive ASEAN Common Technical Dossier preparation customized for rapid product registration. We align your manufacturing and stability data with the specific regulatory expectations of Southeast Asian member states.

Customized dossier compilation meeting the precise local requirements of diverse health authorities. We provide targeted compliance pathways for Latin America, Africa, CIS countries, and emerging global markets.

Secure Your Regulatory Pathway

Pre-empt health authority queries before they cause twelve-month launch delays. Our specialized consultants audit your raw validation and stability data to establish a secure, zero-delay compliance pathway.